BIOREM Inc.
BIRMF
$1.49
$0.04363.01%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 106.80% | -50.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 106.80% | -50.47% | |||
| Cost of Revenue | 97.13% | -54.24% | |||
| Gross Profit | 138.33% | -32.24% | |||
| SG&A Expenses | 49.73% | -22.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 86.48% | -49.41% | |||
| Operating Income | 1,401.96% | -78.82% | |||
| Income Before Tax | 1,980.68% | -79.44% | |||
| Income Tax Expenses | 1,987.10% | -81.10% | |||
| Earnings from Continuing Operations | 1,978.38% | -78.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,978.38% | -78.77% | |||
| EBIT | 1,401.96% | -78.82% | |||
| EBITDA | 483.33% | -50.21% | |||
| EPS Basic | 2,300.00% | -82.05% | |||
| Normalized Basic EPS | 2,283.33% | -82.35% | |||
| EPS Diluted | 1,964.29% | 108.38% | |||
| Normalized Diluted EPS | 1,950.00% | -82.35% | |||
| Average Basic Shares Outstanding | -13.74% | 18.67% | |||
| Average Diluted Shares Outstanding | 0.13% | 18.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||